Our Services
Do You Have a Case?
Illinois Avandia Lawsuit Law FirmChicago Unsafe Pharmaceutical Attorneys
Avandia is a prescription medication approved by the U.S. Food and Drug Administration (FDA) to improve blood sugar control and help sensitize the body to insulin in adults with type 2 diabetes (non-insulin-dependent diabetes). Since its approval in 1992, over 10 million Americans have been prescribed this drug. The skilled Chicago unsafe pharmaceutical attorneys at The Law Group, Ltd. have the experience necessary to maximize monetary compensation for those who have sustained injuries due to the negligence of Avandia’s manufacturers. Contact one of our knowledgeable Avandia attorneys to learn more about a potential claim for injuries suffered as a result of taking Avandia.
The FDA first issued an important safety alert in 2007 after reviewing studies submitted by GlaxoSmithKlein that illustrated a 30% increased risk of heart attacks and heart-related deaths associated with taking Avandia. As a result the FDA began requiring Avandia’s manufacturer to include “black box” warnings on the drug’s label.
The New England Journal of Medicine also published an article regarding health risks associated with Avandia in 2007, showing that those who took Avandia had a 43% increased risk of having a heart attack than patients who were given other medications or a placebo. Moreover, people who took Avandia had a 64% increased risk of dying of cardiovascular causes.
Other drugs in the same class as Avandia, known as peroxisome-proliferato-activated receptors or (PPAR’s), were either withdrawn from the market due to fatal liver toxicity or were never approved by the FDA due to safety concerns in the past several years. Leading experts question the safety effects of Avandia and other PPAR drugs because they are linked to congestive heart failure due to their association with edema (or fluid buildup).
Injuries The following injuries have been associated with Avandia and PPAR drugs: • Congestive heart failure
Avandia Litigation In 2007, multi-district litigation was created by the Judicial Panel on Mulidistrict Litigation to address common issues of fact regarding GlaxoSmithKlein's manufacture and marketing of Avandia. In 2010, additional Avandia lawsuits were removed to federal court and then transferred to multi-district litigation in the eastern district of Pennsylvania.
According to confidential government reports, hundreds of people taking Avandia needlessly suffer heart attacks and heart failure each month. In 2010, the Senate Finance committee concluded that GlaxoSmithKline was aware of the risks, but minimized the issue and attempted to suppress concerned physicians.
If you or someone you know has sustained injuries from Avandia or other PPRAR’s, contact the Chicago, Illinois Avandia litigation lawyers at The Law Group at (312) 558-6444 to have your case evaluated by an experienced defective pharmaceutical attorney. You may be eligible for compensation for medical expenses, loss of income, partial or permanent disability and psychological suffering. |